Clinical Trial Update: Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS) [Phase 3]

View source ↗

Summary

A Phase 3 trial (KALOS) evaluating PT010 in adults and adolescents with inadequately controlled asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PT010

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED